| 000 | 00778nam a22002777a 4500 | ||
|---|---|---|---|
| 999 |
_c63379 _d63379 |
||
| 003 | WUSLLib | ||
| 008 | 230301b ||||| |||| 00| 0 eng d | ||
| 020 | _a0443071454 | ||
| 041 | _aEnglish | ||
| 082 |
_a615.1 _bPHA |
||
| 100 |
_aRang, H.P. _925122 |
||
| 245 | _aPharmacology | ||
| 250 | _a05th ed. | ||
| 260 |
_aEdinburgh: _bChurchill Livingstone; _c2003, _g2003. |
||
| 300 |
_axii, 797p.: _bcol. ill. _c;27cm. |
||
| 650 |
_aPharmacokinetics _925607 |
||
| 650 |
_aMuscle contraction _925608 |
||
| 650 |
_aDrug absorption _925609 |
||
| 650 |
_aChemical mediators _925610 |
||
| 650 |
_aNervous system _98020 |
||
| 650 |
_aAntibacterial drugs _925611 |
||
| 700 |
_aDale, M.M. _925124 |
||
| 700 |
_aRitter, J.M. _925125 |
||
| 700 |
_aMoore, R.K. _925612 |
||
| 942 |
_2ddc _cSR |
||